Celularity Inc.: 10-Q filed 2021-08-19
What Celularity Inc. reported in its quarterly report filed 2021-08-19 (fiscal Q2 2021): 20 published measures, 54 facts as tagged in accession 0001213900-21-043760.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2021-08-19
- Fiscal period
- fiscal Q2 2021
- Accession
- 0001213900-21-043760 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Celularity Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-06-30 | 128,415,406 | USD | |
| At 2020-12-31 | 292,156,433 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-06-30 | 47,454,511 | USD | |
| At 2020-12-31 | 78,022,974 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-06-30 | -47,404,604 | USD | |
| At 2021-03-31 | -39,582,937 | USD | |
| At 2020-12-31 | 5,000,002 | USD | |
| At 2020-06-30 | 5,000,007 | USD | |
| At 2020-03-31 | 5,000,008 | USD | |
| At 2019-12-31 | 5,000,001 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-06-30 | 211 | USD | |
| At 2020-12-31 | 314,696 | USD | |
| At 2020-06-30 | 716,700 | USD | |
| At 2019-12-31 | 917,007 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-04-01 to 2021-06-30 | -7,130,104 | USD | 91 |
| 2021-01-01 to 2021-06-30 | 30,898,858 | USD | 181 |
| 2020-04-01 to 2020-06-30 | -12,109,838 | USD | 91 |
| 2020-01-01 to 2020-06-30 | -5,741,401 | USD | 182 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-06-30 | -828,940 | USD | 181 |
| 2020-01-01 to 2020-06-30 | -774,010 | USD | 182 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-06-30 | 1,109,270 | USD | 181 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-06-30 | -594,815 | USD | 181 |
| 2020-01-01 to 2020-06-30 | 573,703 | USD | 182 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-06-30 | -47,405,323 | USD | |
| At 2020-12-31 | -43,382,625 | USD |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-04-01 to 2021-06-30 | 43,700 | USD | 91 |
| 2020-04-01 to 2020-06-30 | -38,170 | USD | 91 |
| 2020-01-01 to 2020-06-30 | 234,469 | USD | 182 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-04-01 to 2021-06-30 | -1,538,681 | USD | 91 |
| 2021-01-01 to 2021-06-30 | -3,588,802 | USD | 181 |
| 2020-04-01 to 2020-06-30 | -208,233 | USD | 91 |
| 2020-01-01 to 2020-06-30 | -449,872 | USD | 182 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-06-30 | 57,811 | USD | |
| At 2020-12-31 | 359,289 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-06-30 | 7,292,011 | USD | |
| At 2020-12-31 | 3,409,872 | USD |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-12-31 | 48,381,093 | USD |
Total equity including noncontrolling interests
Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-06-30 | -47,404,604 | USD | |
| At 2020-12-31 | 5,000,002 | USD |
Net deferred tax liabilities
Deferred tax liabilities net of related assets under this concept. The amount reflects timing differences and is not tax currently due.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-12-31 | 602 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-04-01 to 2021-06-30 | -7,086,404 | USD | 91 |
| 2021-01-01 to 2021-06-30 | 30,898,858 | USD | 181 |
| 2020-04-01 to 2020-06-30 | -12,148,008 | USD | 91 |
| 2020-01-01 to 2020-06-30 | -5,506,932 | USD | 182 |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-04-01 to 2021-06-30 | -7,130,104 | USD | 91 |
| 2021-01-01 to 2021-03-31 | 38,028,962 | USD | 90 |
| 2020-04-01 to 2020-06-30 | -12,109,838 | USD | 91 |
| 2020-01-01 to 2020-03-31 | 6,368,437 | USD | 91 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-04-01 to 2021-06-30 | -5,547,723 | USD | 91 |
| 2021-01-01 to 2021-06-30 | 34,487,660 | USD | 181 |
| 2020-04-01 to 2020-06-30 | -11,939,775 | USD | 91 |
| 2020-01-01 to 2020-06-30 | -5,057,060 | USD | 182 |
Deferred income tax expense or benefit
The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-06-30 | -602 | USD | 181 |
| 2020-01-01 to 2020-06-30 | -7,085 | USD | 182 |
Inspect the source
- Entity
- Celularity Inc. / CIK 0001752828
- Captured
- 2026-09-21T17:29:07.737Z
- SEC response SHA-256
732b52ad9f2d29e719fef49cad3d40c16039c1cb3073b05f4cf01eb23c287447
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001752828.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))